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Abstract	  	  
Neurosurgical Clipping versus Endovascular Coiling for treating Ruptured Intracranial 
Aneurysm – A study of 98 patients from Western Sweden, 
Master thesis - Programme in Medicine, Hugo Jakobsson 2015, Department of Neurosurgery, 
Sahlgrenska University Hospital, Gothenburg, Sweden 
 
	   3	  
Background	  and	  purpose	  
A ruptured intracranial aneurysm can be treated either by endovascular coiling (EVT) or 
neurosurgical clipping (NST). International Subarachnoid Aneurysm Trial (ISAT), a 
multicenter prospective randomized study, was conducted to compare the two treatment 
alternatives. Criticism has been raised against the low external validity of the study. The 
purpose of this study was to analyze the ISAT material collected at Sahlgrenska university 
hospital (SU) to compare the treatment modalities in the patient population of a single center. 
 
Method	  
The protocols from ISAT were reviewed and a database was created. The primary end-points 
were neurological outcome, assessed with modified Rankin scale (mRS), at two months, one 
year and five years. Length of stay in intensive care unit (ICU), neurosurgical ward, total 
period under care, rate of shunt dependent hydrocephalus (SDHC), occurrence of epileptic 
seizures, rebleeding and need for retreatment were also studied.  
 
Results	  
This study found a good neurological outcome (mRS 0-2) in 76.9%, 84.4% and 76.9% of the 
EVT-patients at two months, one year and five years respectively. The corresponding figures 
for the NST-group were 69.6%, 78.3% and 78.3%. Six (11.5%) EVT-patients developed 
SDHC, 5 (9.6%) EVT-patients had at least one epileptic seizure. Seven (15.2%) EVT-patients 
developed SDHC and 7 (15.2%) had at least one epileptic seizure. EVT-patients spent on 
average 8.8 (SD 7.6) days in ICU, 16.8 (SD 8.8) days in neurosurgical ward and 44.3 (SD 
85.4) days total under care. The NST-patients spent on average 10.6 (SD 7.9) days in ICU, 
18.7 (SD 7.8) days in neurosurgical ward and 62.0 (SD 77.4) days total under care.  
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Conclusions	  
EVT entails a better neurological outcome than NST at two months and one year, but the 
difference diminishes over time. EVT is followed by shorter periods in ICU, neurosurgical 
ward and total period under care. The risk of SDHC is equal for the methods, although 
patients with a high Fisher grade and high age treated with NST are at lower risk than those 
treated with EVT and vice versa for patients with low Fisher grade and low age. 
 
Background	  
An aneurysmal subarachnoid hemorrhage (aSAH) is a serious condition with a mortality rate 
up to 40 % at one month [1]. The incidence of aSAH varies greatly; from 2.0/100 000 
population in Beijing, China, to 22.5/100 000 population in Finland [2]. If untreated, the 
surviving patients are at high risk for rebleeding from the aneurysm. A mortality rate of 22% 
in occurrence of rebleeding has been observed [3]. 
 
Cerebral aneurysms have traditionally been treated by applying a metal clip to the aneurysm 
neck, preventing further bleeding. This procedure involves craniotomy and dissection of 
cerebral blood vessels [4]. Possible complications after the neurosurgical treatment (NST) are 
cerebral infarction, postoperative hematoma, wound infection, meningitis and cranial nerve 
palsy [5]. Advantages include definitive diagnosis of aneurysm rupture in case of multiple 
aneurysms and definitive treatment with a low risk for incomplete aneurysm occlusion and 
regrowth [5-7]. Theoretically the opening of the subarachnoid spaces and irrigation of blood 
can decrease the risk of vasospasm and hydrocephalus after aSAH.  
 
Endovascular embolization became an alternative treatment method of cerebral aneurysms 
when Guido Guglielmi introduced the detachable coil [8]. The endovascular treatment (EVT) 
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uses a micro catheter guided from a. femoralis, via the arterial system, into the lumen of the 
aneurysm where platinum coils are deployed. The platinum coils are detached from the guide 
wire by applying a low positive direct current to the delivery wire. The positive electric 
current attracts negatively charged particles in the blood and causes thrombosis of the 
aneurysm. Possible complications after EVT are periprocedural aneurysm rupture, distal 
thromboembolism, mechanical vasospasm, coil migration and groin complication [5, 6]. 
Incomplete treatment with residual aneurysm have been seen in 22-42 % of cases and 
retreatment after EVT is more often needed than after NST [5-7]. 
 
Koivisto et al. published the first randomized trial comparing the two methods. Their study 
included 109 patients, 57 patients were assigned to NST and 52 to EVT. The outcome was 
measured at 3 and 12 months. Similar results in neurological- and neuropsychological 
outcome were obtained with the two methods [9]. 
 
Two major studies comparing results between EVT and NST after the study of Koivisto are 
the International Subarachnoid Aneurysm Trial (ISAT) and Barrow Ruptured Aneurysm Trial 
(BRAT) [10, 11]. 
 
ISAT was a prospective randomized study conducted by Molyneux et al. It included 2143 
patients from forty-two centers in North America, Australia and Europe. Patients who were 
equally suited for NST and EVT were eligible for the study. For detailed inclusion and 
exclusion criteria see Molyneux et al.,	  2002	  [11]. The study showed a significant higher 
proportion with good neurological outcome at two months and one year in patients treated 
endovascularly compared to those treated neurosurgically [12]. In the long-term follow up, 
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published in 2009, this difference in the surviving patients was no longer significant. Further 
it showed a higher risk for rebleeding and retreatment after EVT than NST [13]. 
 
The ISAT has been criticized for bias in patient selection. The results are not generalizable to 
the whole population since a significant part of the eligible patients were excluded. A total of 
9559 patients were treated for aSAH in the participating centers. Of these 2143 patients 
(22.4%) fulfilled the criteria for inclusion in ISAT, and consented. One thousand seventy 
three were randomized to EVT and 1070 to NST. At one year 2110 patients were eligible for 
assessment of the neurological outcome, 22.1% of the total cases of ruptured intracranial 
aneurysms. Further, the inclusion rate ranged between the participating centers from 1% to 
44%. This characterizes the heterogeneity of the patient assessment [11, 12]. 
 
Spetzler et al. published in July 2013 the three years result of BRAT. In this study all patients 
admitted with a ruptured intracranial aneurysm that consented were randomized. Two 
hundred thirty three were assigned to EVT, of these 38% crossed over to NST. Two hundred 
thirty eight were assigned NST, of these 2% crossed over to EVT. At one year there was a 
significant higher risk for bad neurological outcome in patients treated neurosurgically. The 
result at three years showed, in contrast to the one-year result, no significant difference 
regarding bad neurological outcome [10]. The great number of crossovers from EVT to NST 
makes the results less reliable. 
 
 
This study, which is based on the data collected for ISAT at the Department of Neurosurgery, 
Sahlgrenska University hospital (SU), lacks some of these weaknesses. The patient inclusion 
rate was slightly higher than ISAT, 27.4%. Of these, a greater part of the patients were 
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followed up. At five years, mRS was missing from 3 (3.1%) patients compared to 202 (9.4%) 
patients in ISAT long-term follow up [13]. The patients were treated in a neurovascular center 
serving a large population, with well-developed routines for aSAH patients. This allowed for 
the patient to be treated without delays and by physicians who perform the procedures on a 
regular basis. This provides safety regarding the uniformity of the procedures and treatment 
protocols and the assessment of the endpoints. Further, 87 % of the patients had an aneurysm 
in the anterior circulation compared to 97% in ISAT [11]. This reflects the proportion of the 
whole aSAH population better [14]. 
 
Shunt	  dependent	  hydrocephalus	  
Some studies suggest that the risk of shunt dependent hydrocephalus (SDHC) is higher in 
patients treated endovascularly compared to those treated neurosurgically. Nam et al. studied 
the risk for SDHC in a retrospective study of 839 patients. They showed that the risk for 
SDHC in patients with Fisher grade 4 was significantly lower if they were treated 
neurosurgically. Also that in patients with Fisher grade 2 treated endovascularly the risk for 
SDHC was significantly lower [15].  
 
Retreatment	  
Studies have indicated that EVT is associated with a better short-term neurological outcome, 
but that the differences diminish over time. However, it has been shown that EVT is 
associated with a higher rate of retreatment. In ISAT it was concluded that the patients treated 
endovascularly were 6.9 times more likely to undergo a late retreatment (at least 1 month after 
the first NST or 3 months after the first EVT) [7].  
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Aim	  
The aim of this study was to determine possible differences between endovascular coiling and 
neurosurgical clipping, primarily in neurological outcome, in the cohort treated at SU from 
ISAT. Further endpoints were rate of SDHC, rebleeding, need for retreatment, occurrence of 
epileptic seizures, and length of stay in ICU, neurosurgical ward and total period under care. 
Possible factors in the baseline data correlating with neurological outcome or SDHC was to 
be identified. 
 
Methods	  
 
Population	  and	  data	  collecting	  
This study is based on the patients included in ISAT at the Department of Neurosurgery, SU, 
between March 1997 and April 2002. The patient data were collected at SU according to the 
ISAT-protocol [11]. For the present study the data was collected from the 100 ISAT charts, 
each patient chart was reviewed. The protocol over the excluded patients was reviewed and 
the reason for exclusion and treatment method were noted. Crossovers were considered to the 
randomized group. 
 
Variables	  
The baseline data and endpoints were collected from the patient material of the ISAT. The 
baseline data was age at aneurysmal subarachnoid hemorrhage, sex, Fisher grade, localization 
of aneurysm (anterior/posterior circulation), aneurysm size, aneurysm neck size (>/≤4mm), 
vasospasm (angiographic) and treatment method. Neurological outcome at two months, one 
year and five years were the primary endpoints. 
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Neurological outcome was assessed at two months, one year and five years after aSAH. It was 
assessed according to the modified Rankin scale (mRS, defined in table 1) [16]. Good 
neurological outcome was defined as mRS 0-2, and bad neurological outcome mRS 3-6. 
Time in intensive care unit (ICU), time in neurosurgical ward. In cases where death occurred 
before discharge, the number of days elapsed until death was recorded. 
Total length of care was defined as days from hospital admission to the return to home.  
Epileptic seizure. Patients that suffered at least one epileptic seizure during the follow up time 
of 5 years were recorded. 
Shunt dependent hydrocephalus. Patients that had a shunt inserted during the follow up period 
were recorded. Several patients may have temporarily had ventricular drainage during the 
acute stage, but these were not recorded in this study. 
Retreatment. The patients that underwent at least one retreatment during five years after 
aSAH were recorded. 
Rebleeding events were recorded during the follow up time of five years. 
 
Statistical	  analysis	  
The baseline data were analyzed with Mann-Whitney U-test (age), Mantel Haenszel Chi-
square test (Fisher grade, aneurysm size and WFNS grade), Fisher’s exact test (aneurysm 
neck size, location of the aneurysm, vasospasm and gender). End point analysis included; for 
comparison between groups Fisher’s exact test was used for dichotomous variables 
Table	  1.	  modified	  Rankin	  scale	  (mRS)	  mRS	   Symptoms	  0	   No	  symptoms	  1	   No	  significant	  disability.	  Able	  to	  carry	  out	  all	  usual	  activities,	  despite	  some	  symptoms.	  2	   Slight	  disability.	  Able	  to	  look	  after	  own	  affairs	  without	  assistance,	  but	  unable	  to	  carry	  out	  all	  previous	  activities.	  3	   Moderate	  disability.	  Requires	  some	  help,	  but	  able	  to	  walk	  unassisted.	  4	   Moderately	  severe	  disability.	  Unable	  to	  attend	  to	  own	  bodily	  needs	  without	  assistance	  or	  unable	  to	  walk	  unassisted.	  5	   Severe	  disability.	  Requires	  constant	  nursing	  care	  and	  attention,	  bedridden.	  6	   Dead.	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(retreatment, SDHC, vasospasm and epileptic seizures), Mantel-Haenzel Chi-square exact test 
was used for ordered categorical variables (neurological outcome) and the Mann-Whitney U-
test was used for continuous variables (days in ICU, neurosurgical ward, total period under 
care). To investigate factors that could predict a bad neurological outcome and SDHC, 
bivariate prediction was used. Spearman correlation analysis was performed to investigate the 
correlation between neurological outcome and baseline variables. The level of significance 
was set to p<0.05. 
 
Ethics	  
ISAT was approved by the local ethical board. No separate ethical approval was considered 
necessary for this study as only previously collected, coded data, was used and reanalyzed. 
 
Results	  
Figure 1 represents a flow chart where treatment method and reason for exclusion for the 
patients excluded in the SU cohort of ISAT are shown. Of the 100 patients included in ISAT 
2 withdrew and 2 crossed over (1 EVT-NST and 1 NST-EVT). 
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Figure	  1-­‐	  G=WFNS	  grade	  or	  age,	  A=	  unsuitable	  anatomy,	  O=	  other,	  L=	  aneurysm	  localization,	  N=non	  
availability	  of	  radiologist	  or	  surgeon,	  R=refused	  consent,	  E=	  hematoma	  that	  needed	  evacuation	  
 
The baseline characteristics of the two groups were similar, except vasospasm at inclusion 
where 0 EVT-patients and 8 NST-patients were observed, p=0.002. The data are presented in 
table 2. 
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Table 2- Baseline characteristics	  
 EVT NST Total P-­‐value	  
Age    0.827	  Mean (SD)  52.8 (10.7) 53.4 (9.7) 53.1 (10.2) 
Median (min, max) 54.0 (20, 72) 54.5 (29, 71)  
Sex	  
Male 17 (32.7%) 20 (43.5%) 37 (37.8%) 0.302	  Female 35 (67.3%) 26 (56.5%) 61 (62.2%) 
Fisher grade    	  
0 0 (0.0%) 1 (2.2%) 1 (1.0%) 0.615	  
1 2 (3.8%) 5 (10.9) 7 (7.1%) 	  
2 14 (26.9%) 10 (21.7%) 24 (24.5%) 	  
3 18 (34.6%) 12 (26.1%) 30 (30.6%) 	  
4 18 (34.6%) 18 (39.1%) 36 (36.7%) 	  
WFNS grade pre procedure    	  
1 30 (57.7%) 28 (60.9%) 58 (59.2%) 0.544	  
2 14 (26.9%) 13 (28.3%) 27 (27.6%) 	  
3 2 (3.8%) 1 (2.2%) 3 (3.1%) 	  
4 5 (9.6%) 4 (8.7%) 9 (9.2%) 	  
5 1 (1.9%) 0 (0.0%) 1 (1.0%) 	  
Aneurysm lumen size    	  
≤5 mm 26 (50.0%) 23 (50.0%) 49 (50.0%) 1.000	  
6-10 mm 20 (38.5%) 18 (39.1%) 38 (38.8%) 	  
≥11 mm 5 (9.6%) 5 (10.9%) 10 (10.2%) 	  
Data missing 1 (1.9%) 0 (0.0%) 1 (1.0%) 	  
Aneurysm neck size    	  
>4 mm 22 (42.3%) 20 (43.5%) 42 (42.9%) 1.000	  ≤4 mm 30 (57.7%) 26 (56.5%) 56 (57.1%) 
Aneurysm localization (circulation)    	  
Anterior 45 (86.5%) 40 (87.0%) 85 (86.7%) 1.000	  Posterior 7 (13.5%) 6 (13.0%) 13 (13.3%) 
Aneurysm localization (main artery)    	  
a. Carotis int. 13 (25.0%) 5 (10.9%) 18 (18.4%) 	  
a. Cerebri ant. 4 (7.7%) 2 (4.3%) 6 (6.1%) 	  
a. Cerebri med. 9 (17.3%) 9 (19.6%) 18 (18.4%) 	  
a. Cerebri post. inf. 0 (0.0%) 1 (2.2%) 1 (1.0%) 	  
a. Comm. ant. 19 (36.5%) 24 (52.2%) 43 (43.9%) 	  
a. Comm. post. 7 (13.5%) 5 (10.9%) 12 (12.2%) 	  
Vasospasm at inclusion    	  
No  52 (100%)  38 (82.6%) 90 (91.8%) 0.002	  
Yes 0 (0%) 8 (17.4%) 8 (8.2%) 	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An overview of the neurological outcome is shown in 
tables 3-5. Of the patients randomized to 
EVT, 40 (76.9%) had a good neurological outcome 
(mRS 0-2) at two months and 32 (69.6%) of the NST-
patients. The absolute difference was 7.3%, p=0.554. 
At one year 44 (84.6%) EVT-patients had a good 
neurological outcome, and 36 (78.3%) of the NST-
patients, p=0.585. At five years, data was missing 
from three patients, 40 (78.4%) of the EVT-patients 
had a good neurological outcome and 36 (81.8%) of 
the NST-patients, p=0.878.  
 
The patients in the EVT-group spent on average 8.75 
days (SD 7.56) in ICU, 16.8 (SD 8.8) in neurosurgical 
ward and the total length of care was 44.3 days (SD 85.4). The corresponding figures for the 
NST-group were 10.6 days (SD 7.9) in ICU, 18.7 days (SD 7.8) in neurosurgical ward and 
62.0 days (SD 77.4) of total length of care. The 
difference of time in ICU and neurosurgical ward was 
not significant, p=0.0937 respectively p= 0.1534, but 
significant in total length of care, p=0.0130. Figures 
2-4 shows how the time spent in ICU, neurosurgical 
ward and total length of care was distributed. 
 
Table 3. Neurological outcome at 2 months	  	   Randomized treatment	  
mRS score EVT NST Total 
0 16 (30.8%) 8 (17.4%) 24 (24.5%) 
1 15 (28.8%) 9 (19.6%) 24 (24.5%) 
2 
 9 (17.3%) 15 (32.6%) 
24 (24.5%) 
3 
 2 (3.8%) 5 (10.9%) 
7 (7.1%) 
4 1 (1.9) 0 1 (1.0%) 
5 4 (7.7%) 6 (13.0%) 10 (10.2%) 
6 5 (9.6%) 3 (6.5%) 8 (8.2%) 
0-2 40 (76.9%) 32 (69.6%) 72 (73.5%) 
3-6 12 (23.1%) 17 (30.4%) 18 (18.4%) P=0.554	   	   	   	  
Table 4. Neurological outcome at 1 year	  	   Randomized treatment	  
mRS score EVT NST Total 
0 19 (36.5%) 8 (17.4%) 27 (27.6%) 
1 13 (25.0%) 12 (26.1%) 25 (25.5%) 
2 12 (23.1%) 16 (34.8%) 28 (28.6%) 
3 1 (1.9%) 2 (4.3%) 3 (3.1%) 
4 0 1 (2.2%) 1 (1.0%) 
5 2 (3.8%) 3 (6.5%) 5 (5.1%) 
6 5 (9.6%) 4 (8.7%) 9 (9.2%) 
0-2 44 (84.6%) 36 (78.3%) 80 (81.6%) 
3-6 8 (15.4%) 10 (21.7%) 18 (18.4%) 
P=0.585    
Table 5.  Neurological outcome at 5 years	  	   Randomized treatment	  
mRS score EVT NST Total 
0 19 (37.3%) 12 (27.3%) 31 (32.6%) 
1 14 (27.5%) 9 (20.5%) 23 (24.2%) 
2 7 (13.7%) 15 (34.1%) 22 (23.2%) 
3 2 (3.9%) 1 (2.3%) 3 (3.2%) 
4 0 0 0 
5 3 (5.9%) 3 (6.8%) 6 (6.3%) 
6 6 (11.8%) 4 (9.1%) 10 (10.5%) 
0-2 40 (78.4%) 36 (81.8%) 76 (80.0%) 
3-6 11 (21.6%) 8 (18.2%) 19 (20.0%) P=0.878	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Figure	  2.	  Days	  spent	  in	  neurosurgical	  ward  Figure	  3.	  Days	  spent	  in	  ICU	   	  
	  
Figure	  4.	  Total	  length	  of	  care 
 
Six (11.5%) EVT-patients and 7 (15.2%) NST-patients developed SDHC, p=0.8098. Five 
(9.6%) EVT- and 7 (15.2%) NST-patients had at least one epileptic seizure during the follow 
up period, p=0.5915. In the EVT-group, 6 (11.5%) patients were retreated, 4 neurosurgically, 
one endovascularly and one with EVT two times and one time NST. Of those randomized to 
neurosurgical clipping, 2 (4.3%) patients were retreated with EVT. The difference was not 
significant, p=0.276. 
 
The result from the Spearman correlation analysis (to investigate factors in the baseline data 
that could influence the neurological outcome) is shown in table 6-8. For the total population, 
the correlation was significant for Fisher grade and neurological outcome at two months, one 
year and five years with p-values of <0.0001, 0.0015 and 0.0065 respectively. Age and 
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neurological outcome had a Spearman correlation coefficient of 0.19716 (p=0.0517). The 
Spearman correlation coefficient for neurological outcome and randomization group was 
0.17426 (p=0.0861), 0.19699 (p=0.0519) and 0.10893 (p=0.2933) at two months, one year 
and five years respectively. 
 
Table 7 shows the result of Spearman correlation analysis of the EVT population. 
Significance was achieved in Fisher grade and neurological outcome at two months, one year 
and five years, p=0.0044, p=0.0448 respectively p=0.0157. As well as aneurysm size and 
neurological outcome at five years, p=0.0424. The Spearman correlation analysis of the NST-
group showed significance for age and neurological outcome at two months, p=0.0159, Fisher 
grade and neurological outcome at two months and one year, p=0.0004 and 0.0074, and sex 
and neurological outcome at five years, p=0.0205. Table 8 shows the result of the Spearman 
correlation test for the NST patients. 
 
 
 
 
 
 
 
 
 
 
 
 
Table	  6.	  Spearman	  correlation	  –	  whole	  study	  population	  	  	   mRS	  at:	   2	  months	   1	  year	   5	  years	  Age	   Rho:	   0.20	   0.08	   0.09	  	   P:	   0.052	   0.45	   0.37	  Localization	   Rho:	   -­‐0.12	   -­‐0.10	   -­‐0.03	  (ant./post.)	   P:	   0.22	   0.31	   0.78	  Fisher	  grade	   Rho:	   0.43	   0.32	   0.28	  	   P:	   <0.0001	   0.0015	   0.0065	  Aneurysm	  size	   Rho:	   0.02	   0.09	   0.12	  	   P:	   0.84	   0.38	   0.25	  Neck	  size	   Rho:	   0.10	   0.12	   0.12	  (>/≤4mm)	   P:	   0.32	   0.25	   0.25	  EVT/NST	   Rho	   0.17	   0.20	   0.11	  	   p:	   0.09	   0.05	   0.29	  Rho=spearman	  correlation	  coefficient,	  p=p-­‐value	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Table 9 shows the result obtained from the bivariate prediction of SDHC analysis. Odds ratio 
(OR) is the ratio for the odds for an increase of the predictor of one unit. In the total 
population an OR of 1.09 (CI=1.01-1.16, p=0.0227) was found for age and SDHC. The 
prediction of SDHC for Fisher grade gave the OR 2.11 (CI=0.98-4.53, p=0.0548). In the EVT 
population prediction of SDHC for Fisher grade showed an OR=8.14 (CI=1.07-62.16, 
Table	  7.	  Spearman	  correlation	  –	  EVT	  patients	  	   mRS	  at:	   2	  months	   1	  year	   5	  years	  Age	   Rho:	   0.10	   -­‐0.09	   0.02	  	   P:	   0.50	   0.55	   0.88	  Localization	   Rho:	   -­‐0.01	   -­‐0.04	   0.03	  (ant./post.)	   P:	   0.92	   0.77	   0.82	  Fisher	  grade	   Rho:	   0.39	   0.28	   0.34	  	   P:	   0.004	   0.04	   0.02	  Aneurysm	  size	   Rho:	   0.15	   0.27	   0.29	  	   P:	   0.30	   0.05	   0.04	  Neck	  size	   Rho:	   0.14	   0.13	   0.15	  (>/≤4mm)	   P:	   0.33	   0.36	   0.31	  Rho=spearman	  correlation	  coefficient,	  p=p-­‐value	  
Table	  8.	  Spearman	  correlation	  –	  NST	  patients	  	   mRS	  at:	   2	  months	   1	  year	   5	  years	  Age	   Rho:	   0.35	   0.28	   0.17	  	   P:	   0.02	   0.6	   0.27	  Localization	   Rho:	   -­‐0.21	   -­‐0.16	   -­‐0.07	  (ant./post.)	   P:	   0.16	   0.29	   0.64	  Fisher	  grade	   Rho:	   0.50	   0.39	   0.24	  	   P:	   0.0004	   0.008	   0.12	  Aneurysm	  size	   Rho:	   0.-­‐0.19	   -­‐0.16	   -­‐0.11	  	   P:	   0.20	   0.28	   0.48	  Neck	  size	   Rho:	   0..1	   0.08	   0.07	  (>/≤4mm)	   P:	   0.93	   0.60	   0.67	  Rho=spearman	  correlation	  coefficient,	  p=p-­‐value	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p=0.0432) and for age OR=1.15 (CI=1.02-1.30, p=0.0222). The NST population showed no 
significant factors for development of SDHC. 
Table 9. Bivariate prediction of SDHC 
  Tot.   EVT   NST   
  No. OR (95% 
CI) 
p-
value 
No. OR (95% 
CI) 
p-
value 
No. OR (95% 
CI) 
p-
value 
Age 20-49 1   0   1   
 50-57 5   2   3   
 58-72 7 1.09 (1.01-
1.16) 
0.23 4 1.15 (1.02-
1.30) 
0.02 3 1.04 (0.95-
1.14) 
0.39 
Circulation Ant. 11   5   6   
 Post. 2 1.22 (0.24-
6.27) 
0.81 1 1.33 (0.13-
13.5) 
0.81 1 1.13 (0.11-
11.5) 
0.92 
Fisher grade 0 0   0   0   
 1 0   0   0   
 2 1   0   1   
 3 5   1   4   
 4 7 2.11 (0.98-
4.53) 
0.55 5 8.14 (1.07-
62.2) 
0.04 2 1.30 (0.59-
2.87) 
0.52 
Size (mm) 2-4 6   3   3   
 5-6 5   3   2   
 7-15 2 0.80 (0.61-
1.05) 
0.11 0 0.66 (0.39-
1.13) 
0.13 2 0.88 (0.64-
1.21) 
0.43 
Aneurysm neck 
size 
≤4 
mm 
8   4   4   
 >4 
mm 
5 0.81 (0.24-
2.68) 
0.73 2 0.65 (0.11-
3.91) 
0.64 3 0.97 (0.19-
4.93) 
0.97 
Randomization 
group 
EVT 6         
 NST 7 1.38 (0.43-
4.44) 
0.59       
 
 
The complete result of the bivariate analysis for prediction of bad neurological outcome (mRS 
3-6) is shown in table 10. At two months, one year and five years, age and Fisher grade was 
significantly associated with bad neurological outcome.  
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Table 10. Bivariate prediction of bad neurological outcome (mRS 3-6) 
  2 months 1 year 5 years 
  No. OR (95% 
CI) 
p-
value 
No. OR (95% 
CI) 
p-
value 
No. OR (95% 
CI) 
p-
value 
Age 20-49 5  1.07 (1.02-
1.13) 
0.008 3 1.07 (1.01-
1.13) 
0.028 3 1.07 (1.01-
1.14) 
0.02 
 50-57 7    7   7   
 58-72 14    8   9   
Sex Male 11   9   8   
 Female 15 0.77 (0.31-
1.92) 
0.58 9 0.54 (0.19-
1.51) 
0.24 11 0.85 (0.31-
2.36) 
0.75 
circulation Ant. 24   18   19   
 Post. 2 0.46 (0.10-
2.24) 
0.34 0 N/A 0.12 0 N/A 0.15 
Fisher grade 0 0   0   0   
 1 0   0   0   
 2 2   1   1   
 3 7   6   6   
 4 17 3.27 (1.68-
6.38) 
0.0005 11 2.74 (1.31-
5.71) 
0.007 12 3.08 (1.46-
6.49) 
0.003 
Size (mm) 2-4 9   7   6   
 5-6 7   3   5   
 7-15 10 1.00 (0.87-
1.16) 
0.95 8 1.05 (0.89-
1.23) 
0.55 8 1.07 (0.91-
1.25) 
0.42 
Aneurysm neck 
size 
≤4 mm 14   10   11   
 <4 mm 12 1.20 (0.49-
2.96) 
0.69 8 1.08 (0.39-
3.03) 
0.88 8 1.00 (0.36-
2.77) 
1.00 
Randomization 
group 
EVT 12   8   11   
 NST 14 1.46 (0.59-
3.59) 
0.41 10 1.53 (0.55-
4.27) 
0.42 8 0.81 (0.29-
2.23) 
0.68 
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Discussion	  
This study found that a larger proportion of the patients treated endovascularly had a good 
neurological outcome (mRS 0-2) at two months. The difference was not significant and 
diminished over time. At five years the proportion of NST-patients with a good neurological 
outcome was slightly higher than for the EVT-patients. Similar pattern was found in ISAT 
and BRAT, where they found a significantly better neurological outcome for EVT at the short 
term follow up, but at the long term follow up in ISAT and at the 3 years follow up in BRAT 
the difference was no longer significant [10, 13]. In this study mRS was missing from 2 
patients in the NST-group and 1 patient in the EVT-group, which could have influenced the 
result. 
 
Another finding worth noticing was that the neurological outcomes recorded in this study 
were better than those of ISAT. In ISAT 73.9% of the EVT-patients and 63.1% of the NST 
patients had a good neurological outcome at two months [12]. Reasons for this may be a well 
developed pre- and in-hospital treatment algorithm for aSAH patients, where all patients are 
referred without delay to a specialized neurosurgical center (SU) after diagnosis of aSAH. 
The hospital also serves a large population, which gives the operators experience in the 
procedures. This is supported by a meta-analysis by Boogaarts et al. They found that 
neurovascular centers with a high number of treated patients achieved better outcomes [17]. 
Inconsequent assessment of mRS-score and inappropriate patient exclusion in the 
participating centers should also be considered as reasons. 
 
The absolute difference in proportion of patients suffering at least one epileptic seizure during 
the follow up time was 5.6% favoring EVT, p=0.5915, and in line with the result of ISAT. 
The authors of ISAT concluded that a significant larger proportion of the aSAH-patients 
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treated with NST had epileptic seizures than those treated with EVT [18]. NST involves brain 
retraction and it is possible that the higher rate of epileptic seizures depends on this.  
 
In this study 6 (11.5%) of the EVT patients and 2 (4.3%) of the NST patients had to undergo 
at least one extra procedure, p=0.276. Similar results were found in ISAT when comparing 
the rate of retreatment between the two methods. In the EVT group, retreatment was 
performed in 191 (17.4%) of 1096 cases compared to 39 (3.8%) 1012 cases in the NST group. 
The authors concluded that the patients were 6.9 times more likely to need a late retreatment 
(at least 1 month after NST or 3 months after EVT) after endovascular coiling [7].  
 
The purpose of treating a ruptured intracranial aneurysm is to prevent rebleeding. In previous 
studies the neurosurgical method has proven to provide sufficient protection to rebleeding. In 
this study two of the EVT patients and none of the NST patients rebled. The difference was 
not significant but in ISAT, the endovascular method had a higher risk of rebleeding. The 
UK-cohort of ISAT was analyzed with a follow up time of 10-18.5 years and over three times 
as many EVT-patients as NST-patients rebled [19]. Despite the difference in rebleeding, no 
difference was found in neurological outcome. The average age of the patients in this study 
was 53.1 years (SD 10.2). Taking into consideration that many patients have an expected 
remaining lifetime of almost 30 years, it must be ascertained that EVT provides a secure 
protection for that period of time. Further analyzes with longer follow up time of the ISAT 
material would be useful to conduct, in order to assess the endurance of the endovascular 
treatment. 
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Craniotomy and subsequent rinsing of the subarachnoid spaces may decrease the risk of 
developing hydrocephalus after aSAH. Nam et al. concluded, in a retrospective study of 839 
patients with aSAH, that patients with Fisher grade 4 treated neurosurgically have a lower risk 
of developing SDHC compared to those treated endovascularly, and patients with Fisher 
grade 2 treated endovascularly have a lower risk of developing SDHC than those treated 
neurosurgically. This study found no difference in rate of SDHC between the treatment 
modalities during the follow up time of 5 years. However, the bivariate prediction analysis 
showed that Fisher grade significantly predicts SDHC rate in the EVT group, p=0.0432, but 
not in the NST group, p=0.5174. Similar results were obtained between age and SDHC. High 
age was correlated to a smaller increase of risk of developing SDHC than high Fisher grade. 
Hence high age and, especially high Fisher grade might be associated with an increased risk 
of developing SDHC in patients treated endovascularly but not in patients treated 
neurosurgically. Thus, patients with Fisher grade 4 could be treated with NST to minimize the 
risk of SDHC. These conclusions also implicate a reversed relationship for patients with low 
Fisher grade. The risk of SDHC development is higher in younger NST-patients with low 
Fisher grade than the EVT-patients with the same age and Fisher grade.  
 
Concerning the total period under care, a significant difference was found in favor for EVT. 
EVT patients spent shorter periods in ICU and neurosurgical ward as well, but the differences 
were not significant, p=0.1534 respectively 0.0937. These findings reflect the results of 
neurological outcome, where NST patients had higher mRS scores at two months, indicating 
they needed longer time to recover. In addition to patients suffering, this is interesting in a 
health economic perspective where a prolonged stay in ICU, neurosurgical ward and total 
length of care increases the costs. An analysis comparing the overall costs for EVT and NST, 
from randomization to 24 months after treatment, was made in a subgroup of ISAT. The 
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authors did not find a significant difference despite the higher cost of the endovascular 
procedure per se [20].  
 
The analysis for identifying predictors for bad neurological outcome showed that a high 
Fisher grade was the most prominent factor; age had a significant influence as well. The 
factors investigated were age, aneurysm localization, Fisher grade, aneurysm size, aneurysm 
neck size and randomization group. The bivariate prediction of mRS 3-6 showed that a high 
Fisher grade entailed a significantly greater risk of death or dependency at two months. Age 
could predict the risk of bad neurological outcome as well, though the odds ratio was not as 
high as for Fisher grade. A study by Orbo et al. based on 44 aSAH-patients treated 
neurosurgically support the finding that Fisher grade is an important predictor of neurological 
impairment [21]. 
 
EVT	  or	  NST	  
The endovascular method has an initially better neurological outcome in this study as well as 
in ISAT and in BRAT. There are still concerns about which method is to be preferred. One of 
the difficulties has been the design of the trials. ISAT included only patients, which were 
judge to benefit equally from EVT and NST. In consequence a large part of the patients were 
excluded, 72.6% in this study and 76.6% in ISAT. This limits the possible conclusions, and 
they are not applicable to the excluded patients. BRAT on the other hand included all patients. 
Patients admitted one day was treated with EVT, and the patients admitted the following day 
was treated with NST. The last 100 patients had the procedure selected by randomization. 
After the patients were allocated to a procedure, the responsible physicians could change 
procedure if in their opinion the patient was better suited for the other procedure. This 
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resulted in a large group of crossovers from coiling to clipping. Thus no study can show that 
the results obtained in ISAT and BRAT can be applicable to all aSAH patients. 
 
Although many studies show that EVT is followed by a shorter time of recovery as well as a 
better initially neurological outcome in the studied population, the neurological outcome tells 
just how well the patient endures the procedure and recovers from the aSAH. It does not 
measure the explicit effect of the treatment and durability. A suitable endpoint to survey the 
efficacy of the treatment is the rate of retreatment or rebleeding. If the trend to treat aSAH 
with EVT continues there must be more safety data regarding the durability of the coil 
treatment. Molyneaux et al. have investigated the rate of rebleeding in the UK cohort of 
ISAT. The follow up time was 10-18.5 years and the rate of rebleeding was higher in the EVT 
group. Thirteen (1.6%) of the 809 EVT patients and 4 (0.5%) of the 835 NST patients rebled 
from the target aneurysm in the study [19]. It would be useful to know how this develops over 
an even longer time. Since the mean age for aSAH was 53.1 in this study, the patients have a 
mean remaining lifetime of almost 30 years. Therefore the coils must be able to provide 
protection from rebleeding and regrowth for a longer time than what has been investigated. 
 
ISAT Part II is a trial that is currently in the data-collecting phase. It is planned to enroll at 
least 1896 patients to achieve adequate power to show significance and it is estimated to take 
12 years to complete the trial. It addresses the insecurities after the original ISAT. The study 
will investigate neurological outcome for patients that would have been excluded in the 
original ISAT, the patients with aneurysms that were unsuitable for EVT because of technical 
limitations at the time and now can be treated endovascularly, and factors that could indicate a 
difference in neurological outcome with one of the procedures [22]. To optimize aneurysm 
treatment of aSAH patients both modalities need to be available as the best treatment may 
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differ between aneurysm types. For optimal outcome, excellent aneurysm treatment and ICU 
treatment is paramount, preferably in a high volume center. 
 
Methodological	  considerations	  
The material of this study was collected between 1997 and 2003. Since then technical 
advances have been made, especially in the endovascular intervention field, which have made 
it possible to treat patients who previously were unsuitable for EVT.  
 
The inclusion rate of this study was 27.4%. Although higher than overall ISAT, a significant 
part of the aSAH-patients was excluded. This limits the generalizability of the conclusions. 
 
Many statistical analyses were performed, which obviously increases the risk of type I errors. 
 
 
Conclusions	  and	  implications	  
EVT entails an initially better neurological outcome in the studied populations, the difference 
diminishes over time. EVT patients spend shorter time in hospital. The rates of rebleeding and 
retreatment are higher for EVT. The risk of SDHC in patients with a high Fisher grade is 
lower when treated with NST than with EVT. Further studies must be conducted to assess 
aneurysm regrowth and rebleeding in the long term for EVT. 
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Populärvetenskaplig	  sammanfattning	  
Ett aneurysm är en säckformig utbuktning på en artär som löper en stor risk att brista. I så fall 
sker en subarachnoidalblödning. Detta är ett allvarligt tillstånd med en dödlighet på upp till 40 
% [1]. Behandlingens syfte är att förhindra att ytterligare blödningar från aneurysmet 
inträffar. Det finns två behandlingsalternativ. Endovaskulär embolisering som går ut på att 
man för en kateter från en artär i ljumsken till aneurysmet som man sedan fyller med 
platinaspiral, på så vis kan man få blodet i aneurysmet att koagulera och minska risken för 
ytterligare blödning. Det kirurgiska behandlingsalternativet innebär att skallen öppnas och en 
metallklämma appliceras på aneurysmhalsen. På så vis tätas aneurysmhalsen och blod 
förhindras från att fylla aneurysmet. 
Denna studie syftade till att undersöka skillnader i behandlingsresultat mellan metoderna. Det 
primära utfallsmåttet var neurologiskt tillstånd som mättes med modified Rankin Scale 
(mRS). 
Resultatet visade fördel för den endovaskulära metoden i neurologiska tillstånd vid två 
månader och ett år, men vid fem år hade skillnaden krympt. Andel patienter som behandlats 
endovaskulärt med bra neurologiskt tillstånd (mRS 0-2) var 76.9% vid 2 månader, 84.6% vid 
1 år och 76.9% vid 5 år. Motsvarande siffror för patienter behandlade kirurgiskt var 69.6%, 
78.3 % och 78.3%. Dock pekade denna studie på en högre risk för att nya blödningar från 
aneurysmet inträffar och behov av ytterligare behandling vid endovaskulär behandling.  
Att utreda vilken behandling som ger bäst resultat för en viss patientgrupp kan ge många 
patienter bättre förutsättningar att få en behandling som ger störst möjlighet att återgå till ett 
normalt liv efter blödning från ett intrakraniellt aneurysm. Denna studie kommer vara till 
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gagn för patienter som drabbats av aneurysmala subarchnoidalblödningar, då resultatet kan 
användas som beslutsunderlag vid behandlingen av patienter med subarachnoidalblödning.  
.  
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